DE69622347D1 - Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure - Google Patents

Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure

Info

Publication number
DE69622347D1
DE69622347D1 DE69622347T DE69622347T DE69622347D1 DE 69622347 D1 DE69622347 D1 DE 69622347D1 DE 69622347 T DE69622347 T DE 69622347T DE 69622347 T DE69622347 T DE 69622347T DE 69622347 D1 DE69622347 D1 DE 69622347D1
Authority
DE
Germany
Prior art keywords
nucleic acid
primers
amplification
hcv
oligonucleotide primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69622347T
Other languages
English (en)
Other versions
DE69622347T2 (de
Inventor
Sue Yen Tsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69622347D1 publication Critical patent/DE69622347D1/de
Publication of DE69622347T2 publication Critical patent/DE69622347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69622347T 1995-11-29 1996-11-21 Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure Expired - Lifetime DE69622347T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US773995P 1995-11-29 1995-11-29

Publications (2)

Publication Number Publication Date
DE69622347D1 true DE69622347D1 (de) 2002-08-22
DE69622347T2 DE69622347T2 (de) 2003-02-13

Family

ID=21727873

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622347T Expired - Lifetime DE69622347T2 (de) 1995-11-29 1996-11-21 Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure

Country Status (8)

Country Link
US (1) US5837442A (de)
EP (1) EP0776981B1 (de)
JP (2) JP3814352B2 (de)
AT (1) ATE220726T1 (de)
CA (1) CA2191182C (de)
DE (1) DE69622347T2 (de)
DK (1) DK0776981T3 (de)
ES (1) ES2179909T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070925B1 (en) * 1996-07-16 2006-07-04 Gen-Probe Incorporated Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
EP0866071B1 (de) * 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modifizierte Primer
EP1036847B1 (de) * 1999-02-03 2004-10-27 Ortho-Clinical Diagnostics, Inc. Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
CA2304260C (en) * 1999-04-20 2009-03-24 Japan Bioindustry Association Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method and method for analyzing data obtained by the method
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
CA2439402A1 (en) * 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
EP1236804A1 (de) * 2001-03-02 2002-09-04 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Nukleinsäuren mittels einer Kontrolle
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
KR100440852B1 (ko) * 2001-05-10 2004-07-19 주식회사 바이로메드 레트로바이러스에 특이적인 올리고뉴클레오티드 프라이머및 이를 이용한 레트로바이러스 농도 측정방법
US6946245B2 (en) 2001-12-04 2005-09-20 Quest Diagnostics Investments Incorporated Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
CA2489895A1 (en) * 2002-07-26 2004-02-05 Abbott Laboratories Method of detecting and quantifying hepatitis c virus
WO2004094986A2 (en) 2003-04-16 2004-11-04 Handylab, Inc. System and method for electrochemical detection of biological compounds
US7824857B2 (en) * 2003-12-02 2010-11-02 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
WO2005084254A2 (en) * 2004-02-27 2005-09-15 Musc Foundation For Research Development Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
AU2005271960B2 (en) * 2004-07-09 2011-12-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification of markers in lung and breast cancer
EP1799858A4 (de) * 2004-09-20 2009-03-04 Univ Pittsburgh Multimodus-multiplexlöschverfahren
WO2006085328A2 (en) * 2005-02-14 2006-08-17 Mor Research Applications Ltd. Method and kit for diagnosing and predicting hepatitis c virus-related neoplastic transformation
US8067208B2 (en) * 2005-06-30 2011-11-29 Roche Molecular Systems, Inc. Probes and methods for hepatitis C virus typing using multidimensional probe analysis
EP2405024A1 (de) 2005-07-15 2012-01-11 Life Technologies Corporation Heissstart reverse Transkription durch primer design
CA2571904A1 (en) * 2006-02-15 2007-08-15 Fio Corporation System and method of detecting pathogens
US8119352B2 (en) * 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
CA2580589C (en) 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
US8360321B2 (en) 2007-04-02 2013-01-29 Fio Corporation System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology
US8597729B2 (en) 2007-06-22 2013-12-03 Fio Corporation Systems and methods for manufacturing quantum dot-doped polymer microbeads
US8551786B2 (en) 2007-07-09 2013-10-08 Fio Corporation Systems and methods for enhancing fluorescent detection of target molecules in a test sample
JP5721161B2 (ja) * 2007-08-31 2015-05-20 国立大学法人鳥取大学 ＴＥＲＴ遺伝子のｃＤＮＡの製造、それを用いた核酸増幅法、検出方法、それらに用いるプライマー、及び、それらを用いた腫瘍の診断キット
CN101861203B (zh) 2007-10-12 2014-01-22 Fio公司 用于形成浓缩体积的微珠的流动聚焦方法和系统以及形成的微珠
CN102132330B (zh) 2008-06-25 2015-07-22 Fio公司 生物威胁警报系统
MX2011002235A (es) 2008-08-29 2011-04-05 Fio Corp Dispositivo de prueba de diagnostico portatil de un solo uso, y un sistema y metodo asociado para probar muestras de prueba biologicas y ambientales.
CN104374932A (zh) 2009-01-13 2015-02-25 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
DE3886363T3 (de) 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
WO1990011089A1 (en) 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
DE69033891T2 (de) 1989-05-18 2002-08-29 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
ATE188509T1 (de) 1990-02-16 2000-01-15 Hoffmann La Roche Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
WO1992001814A2 (en) 1990-07-24 1992-02-06 F. Hoffmann-La-Roche Ag The reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
EP0487218B1 (de) 1990-10-31 1997-12-29 Tosoh Corporation Verfahren zum Nachweis oder Quantifizierung von Zielnukleinsäuren
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
ATE161291T1 (de) 1991-08-27 1998-01-15 Hoffmann La Roche Verfahren und reagenzien zum nachweis von hepatitis c
JPH08503600A (ja) * 1992-05-29 1996-04-23 アボツト・ラボラトリーズ Ｒｎａ配列で開始させるリガーゼ連鎖反応
DE69428167T2 (de) * 1993-07-01 2002-05-29 F. Hoffmann-La Roche Ag, Basel Reagenz und Verfahren für reverse Transkription bei hoher Temperatur, verbunden mit einer Polymerase-Kettenreaktion
WO1995006753A1 (en) * 1993-09-03 1995-03-09 The United States of America, represented by The Secretary, Department of Health & Human Services Method and compositions for primer specific solid-phase detection of pcr products
US5491063A (en) 1994-09-01 1996-02-13 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US5571673A (en) 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US9105210B2 (en) 2012-06-29 2015-08-11 Microsoft Technology Licensing, Llc Multi-node poster location

Also Published As

Publication number Publication date
EP0776981A2 (de) 1997-06-04
JP3903059B2 (ja) 2007-04-11
JP2006020642A (ja) 2006-01-26
CA2191182A1 (en) 1997-05-30
JPH09163991A (ja) 1997-06-24
DE69622347T2 (de) 2003-02-13
ATE220726T1 (de) 2002-08-15
EP0776981B1 (de) 2002-07-17
DK0776981T3 (da) 2002-11-11
EP0776981A3 (de) 1998-08-19
CA2191182C (en) 2004-09-21
ES2179909T3 (es) 2003-02-01
US5837442A (en) 1998-11-17
JP3814352B2 (ja) 2006-08-30

Similar Documents

Publication Publication Date Title
DE69622347D1 (de) Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure
DE69223562D1 (de) Verfahren und Reagenzien zum Nachweis von Hepatitis C
DE69627408D1 (de) Primers und Sonden zum Nachweis von HIV
DE69029726D1 (de) Festphasendiagnose von medizinischen konditionen
FI950487A (fi) Menetelmä, reagenssi ja testipakkaus nukleiinihapposekvenssien totamiseksi ja monistamiseksi
ATE345398T1 (de) Primer und kit für den nachweis von chlamydia trachomatis
ATE345400T1 (de) Primern zum nachweis von hiv-1
DK0648845T3 (da) Metode til co-amplificering af to forskellige nucleinsyresekvenser ved hjælp af polymerasekædereaktion
DK0795612T3 (da) Mangfoldiggørelse og påvisning af målnukleinsyrer under anvendelse af et postmangfoldiggørelses-inkubationstrin
EP0922771A3 (de) Verfahren zum Nachweis hoher Virenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
DE69610933D1 (de) Verfahren und reagenzien zur typisierung von hla-genen der klasse i
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
RU93013954A (ru) Способ обнаружения вируса иммунодефицита

Legal Events

Date Code Title Description
8364 No opposition during term of opposition